ArticleThe Journal of clinical investigation2018
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.
Dmitriy Zamarin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
82 papers cite itlatest 60 shown
this papertrialcites it